1.Fetal Cardiotocogram for Prediction of Adverse Neonatal Outcome in Thick Meconium Stained Pregnancy.
Jee Hyun PARK ; Young Goo LIM ; Moon Hwan LIM ; Eun Sub SONG ; In Hwa NO ; Byung Ik LEE ; Jong Hwa KIM
Korean Journal of Obstetrics and Gynecology 2000;43(12):2202-2207
No abstract available.
Cardiotocography*
;
Meconium*
;
Pregnancy*
2.Cloning and Expression of Low Molecule Protein Antigens from Mycobacterium tuberculosis H37Rv.
Jae Hyun LIM ; Hwa Jung KIM ; Eun Kueong JO ; Chang Hwa SONG ; Un Ok KIM ; Jeong Kyu PARK
Journal of the Korean Society for Microbiology 2000;35(5):375-375
No Abstract Available.
Clone Cells*
;
Cloning, Organism*
;
Mycobacterium tuberculosis*
;
Mycobacterium*
3.Iatrogenic Kaposi Sarcoma Developed in a Membranous Glomerulonephritis Patient after High-dose Intravenous Pulse Steroid Therapy.
Eun hwa LIM ; Jeong min HA ; Young joon SEO ; Young LEE ; Myung IM ; Jeung hoon LEE
Korean Journal of Dermatology 2017;55(1):68-69
No abstract available.
Cutaneous Fistula
;
Glomerulonephritis, Membranous*
;
Humans
;
Sarcoma, Kaposi*
4.Effect of Degassing Condition on Ceramic Bond Strength of Ni-Cr Alloys.
Eun Hwa LEE ; Young Chan JEON ; Chang Mo JEONG ; Jang Seop LIM
The Journal of Korean Academy of Prosthodontics 2000;38(4):461-471
This study evaluated the effect of dagassing on the ceramic bond strength of two Ni-Cr alloys under varying holding time at the upper limit temperature and atmospheric conditions. Metal specimens were divided into 5 groups for each alloy according to degassing conditions prior to porcelain application : no degassing, degassing under vacuum without hold, degassing under vacuum with hold for 5min. and 10 min. respectively at the upper limit temperature and degassing in air. Total number of metal ceramic specimens was eighty and each group had eight specimens : The ceramic bond strength was measured by four-point flexural test using Instron and the fractured surface was examined under SEM. The results obtained were as follows. 1. Degassing in air improved the ceramic bond strength of Ni-Cr alloys. 2. in degassing under vacuum, hold at the upper limit temperature was advantageous to the ceramic bonding of Ni-Cr alloys. 3. After ceramic metal bond test, metal surfaces were partially covered with the thin porcelain layer, and the cohesive failures in porcelain were predominant in groups showing higher ceramic bond strength.
Alloys*
;
Ceramics*
;
Dental Porcelain
;
Vacuum
5.The Change of Fetal Liver Length and Liver Volume by Ultra-sonography according to Gestational Age in Normal Pregnancy.
Kwoan Young OH ; Jee Hyun PARK ; In Hwa NO ; Young Koo LIM ; Eun Seop SONG ; Moon Whan IM ; Byoung Ick LEE ; Jong Hwa KIM ; Sun Hee CHEON ; Jungja AHN
Korean Journal of Obstetrics and Gynecology 2000;43(3):437-443
OBJECTIVE: The measurement of liver size can be used for the diagnosis of the fetal growth abnormality (FGR, macrosomia etc.). The purpose of this study was to evaluate a mathematical relationship between the fetal liver size(liver length or volume) and the gestational age in the normal pregnancies. Brief comparisons were also tried on the base of the degree of the correlation between liver length and its volume. METHODS: We collected 54 singleton pregnancies of 20 to 36weeks of gestation for measuring fetal liver length and 57 singleton pregnancies for measuring fetal liver volume. We used Combison 530 utrasonic machine(Kreztechnik AG, Zipf, Austria). RESULTS: There was significant correlation between liver size( length and volume) and gestation age. And the liver volume better correlated with gestational age than liver length(r=0.93 : r=0.78, p<0.0001, p<0.0001). CONCLUSION: Ultrasonic measurement of fetal liver size is a reliable indicator of fetal growth, especially liver volume. Therefore these data may have a potential value for the prediction of abnormal fetal growth(FGR, macrosomia).
Diagnosis
;
Fetal Development
;
Gestational Age*
;
Liver*
;
Pregnancy*
;
Ultrasonics
6.Increased IL-12 and Interferon-Hamma, But Not IL-18 Production, After In Vitro Stimulation with a 30-kDa Mycobacterial Antigen in Patients with Tuberculous Pleurisy.
Chang Hwa SONG ; Eun Kyeong JO ; Hwa Jung KIM ; Jae Hyun LIM ; Un Ok KIM ; Tae Hyun PAIK ; Ji Won SUHR ; Jeong Kyu PARK
Journal of the Korean Society for Microbiology 2000;35(5):358-358
No Abstract Available.
Humans
;
Interleukin-12*
;
Interleukin-18*
;
Tuberculosis, Pleural*
7.The Distribution of CA-125 Level Among the Patients Who Underwent Hysterectomy.
Eun Seop SONG ; Jung Mook YOON ; In Hwa NOH ; Young Koo LIM ; Sung Ook HWANG ; Moon Whan IM ; Byoung Ick LEE ; Jong Hwa KIM
Korean Journal of Gynecologic Oncology and Colposcopy 2000;11(1):55-59
OBJECTIVES: To understand the importance of the serum level of Ca-125 among pelvic mass, we performed a study. METHOD: From January to December 1998, we performed the study. Before hysterectomy, we performed a blood sampling to know the serum level of Ca-125, After hysterectomy, we weighed the uterus and measured the thickness of endometrium and other histologic characteristics. RESULTS: We performed my research to 80 peoples. The relation between uterine weight and the serum level of Ca-125 is little, if ever(R2=0.0007), and the relation between the thickness of endometrium and the serum level of Ca-125 is also little, if ever(R2=0.0353). The relation between leiomyoma, the cycle of endometrium and the serum level of Ca-125 were also little, but there was a close relationship between adenomyosis and the serum level of Ca-125. CONCLUSION: There was little relationship between uterine weight and the serum level of Ca-125.
Adenomyosis
;
Endometrium
;
Female
;
Humans
;
Hysterectomy*
;
Leiomyoma
;
Uterus
8.IL-12 and TNF-alpha productions from human peripheral blood mononuclear cells in untreated patients with active pulmonary tuberculosis stimulated with 30-kDa or TSP antigen of Mycobacterium tuberculosis H37Rv.
Chang Hwa SONG ; Eun Kyeong JO ; Dae Su KIM ; Hwa Jung KIM ; Jae Hyun LIM ; Un Ok KIM ; Tae Hyun PAIK ; Jeong Kyu PARK
Immune Network 2001;1(3):250-259
No abstract available.
Humans*
;
Interleukin-12*
;
Mycobacterium tuberculosis*
;
Mycobacterium*
;
Tuberculosis, Pulmonary*
;
Tumor Necrosis Factor-alpha*
9.Purification and Partial Characterization of the 38 kDa Glycolipoprotein Antigen from the Culture Filtrate of Mycobacterium tuberculosis H37Rv.
Jeong Kyu PARK ; Hee Chul CHANG ; Jae Hyun LIM ; Chang Hwa SONG ; Un Ok KIM ; Eun Kyeong JO ; Hwa Jung KIM
Journal of Bacteriology and Virology 2001;31(3):249-257
Mycobacterium tuberculosis infected macrophages can become ineffective at activating CD4+ T cells through presentation of peptide antigens by MHC class II, possibly contributing to the ability of M tuberculosis to persist despite the presence of an intact immune system. Presentation of lipid antigens may help to overcome this problem. CD1 represents the key component of an MHC independent pathway for presentation nonpeptide lipid antigens to T cells. The 38 kDa glycolipoprotein antigen of M. tuberculosis is actively secreted. The antigen induces strong antibody and T-cell responses and provided partial protection against M. tuberculosis infection in mice when it is administered either entrapped in biodegradable microparticles or in the form of a DNA vaccine. But an selective anergy to stimulation with peptide of the 38 kDa was observed in the majority of tuberculosis patients. An 38 kDa antigen has been isolated by affinity chromatography using a monoclonal antibody. This antigen contains some immunosuppressive cell wall associated antigens such as lipoarabinomannan. Therefore, we purified the 38 kDa glycolipoprotein from the culture filtrate of M tuberculosis H37Rv by ammonium sulfate precipitation (55~80%), hydroxylapatite and DEAE-Sephacel column. The purified antigen showed three major bands on isoelectric focusing gel, and two-dimensional electrophoresis (2-DE) analysis of this antigen revealed five distinct spots of the 38 kDa molecular mass. One of five spots had a N-terminal sequence identical to that of the 38 kDa glycolipoprotein (pstS-1). Other protein spots could not determine sequences. An antiserum against the recombinant 38 kDa antigen of M tuberculosis reacted strongly with the purified the 38 kDa antigen.
Ammonium Sulfate
;
Animals
;
Cell Wall
;
Chromatography, Affinity
;
DNA
;
Durapatite
;
Electrophoresis
;
Humans
;
Immune System
;
Isoelectric Focusing
;
Macrophages
;
Mice
;
Mycobacterium tuberculosis*
;
Mycobacterium*
;
T-Lymphocytes
;
Tuberculosis
10.Clinicopathologic Comparison between Autoimmune Cholangitis and Primary Biliary Cirrhosis.
Gyeong Hoon KANG ; So Dug LIM ; Eun Sil YU ; On Ja KIM ; Geun Chan LEE ; Neung Hwa PARK ; Dong Jin SUH
Korean Journal of Pathology 1998;32(2):115-124
Primary biliary cirrhosis (PBC) is characterized by histological findings of an immunoinflammatory destruction of small- and medium-sized bile ducts with progressive portal fibrosis, and the presence of anti-mitochondrial antibody (AMA) with a laboratory evidence of chronic cholestasis. The term "autoimmune cholangitis" (AIC) is used for a disease with the clinical and pathologic features of primary biliary cirrhosis (PBC) but with negative AMA and positive anti-nuclear antibody (ANA) tests. Eight cases of AIC and ten cases of PBC were reviewed in order to determine whether there was any difference between two diseases in clinico-pathologic aspects. All of the patients were female and the mean ages of AIC and PBC patients were 48 and 47 years, respectively. ANA test was positive in six of ten PBC paients and their mean titer was lower than that of AIC patients. IgM level was significantly higher in PBC group than in AIC group. No significant difference was found between two groups with respect to biochemical and histopathological features. Since the only consistently distinguishing features between these two conditions are the autoantibody profile (AMA vs ANA) and immunoglobulin level (IgM), these two conditions might be part of a spectrum. PBC can be considered to be the same as AMA-positive AIC or alternatively AIC to be the same as AMA-negative PBC.
Bile Ducts
;
Cholangitis*
;
Cholestasis
;
Female
;
Fibrosis
;
Humans
;
Immunoglobulin M
;
Immunoglobulins
;
Liver Cirrhosis, Biliary*